These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3435960)

  • 1. Preparation and evaluation of sustained release tablets prepared with alpha-starch.
    Nakano M; Nakazono N; Inotsume N
    Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4346-50. PubMed ID: 3435960
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative bioavailability of a new sustained-release theophylline tablet.
    Takagi K; Watanabe T; Satake T; Hasegawa T; Ogura Y; Imaeda N; Mizukami Y
    Arerugi; 1987 Nov; 36(11):1006-11. PubMed ID: 3442492
    [No Abstract]   [Full Text] [Related]  

  • 3. Invivo absorption behaviour of theophylline from starch-methyl methacrylate matrix tablets in beagle dogs.
    Fernández-Campos F; Ferrero C; Colom H; Jiménez-Castellanos MR
    Int J Pharm; 2015 Jan; 478(2):684-92. PubMed ID: 25476254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained release matrix tablets prepared from cospray dried mixtures with starch hydrophobic esters.
    Sakhnini N; Al-Zoubi N; Al-Obaidi GH; Ardakani A
    Pharmazie; 2015 Mar; 70(3):177-82. PubMed ID: 25980178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption of theophylline from conventional and sustained-release tablets.
    Mellstrand T; Svedmyr N; Fagerström PO
    Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate.
    Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative bioavailability of sustained-release and conventional tablets of hydroxyethyltheophylline in man.
    Sharma PL; Sharma RM
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):394-6. PubMed ID: 583044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bio-availability of theophylline whole and halved sustained-release tablets.
    Müller FO; Hundt HK; Luus HG; van Dyk M; Groenewoud G; van der Meer MJ; Steinijans VW
    S Afr Med J; 1987 Aug; 72(3):175-8. PubMed ID: 3299763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets.
    Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Thürkow-Luikens AJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):506-10. PubMed ID: 6500770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
    Gupta S; Raina RK; Samotra K; Gupta KL
    Indian J Chest Dis Allied Sci; 1991; 33(1):1-8. PubMed ID: 1791015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO; Mellstrand T; Svedmyr N
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of whole and half Theo-Dur tablets.
    Fagerström PO
    Eur J Respir Dis Suppl; 1980; 109():62-6. PubMed ID: 6934089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative study of the pharmacokinetics of oral preparations of theophylline].
    Tsoĭ AN; Gneushev ET; Maĭorova EM; Gavrilenko LN; Kunes VG
    Farmakol Toksikol; 1990; 53(5):39-42. PubMed ID: 2253747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on the sustained-release theophylline tablet].
    Mao FF; Tu XD; Zhu JB; Zhu YP
    Yao Xue Xue Bao; 1986 Mar; 21(3):213-9. PubMed ID: 3788587
    [No Abstract]   [Full Text] [Related]  

  • 17. [The bioavailability of 4 sustained-release theophylline preparations from the Chilean market].
    Biagini L; Zamora P; Chávez H; Saavedra I
    Rev Med Chil; 1990 Nov; 118(11):1241-6. PubMed ID: 2152650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of circadian variation of serum theophylline concentration and bioavailability between Theo-dur tablet and a new sustained-release theophylline formulation (E-0686 granule)].
    Kishida M; Okuma M; Uekusa T; Akimoto K; Obata T; Akazawa A; Odajima Y; Nagakura T; Iikura Y; Hukushima K
    Arerugi; 1988 Apr; 37(4):218-25. PubMed ID: 3228360
    [No Abstract]   [Full Text] [Related]  

  • 19. Sustained-release theophylline preparations.
    Weinberger MM
    J Allergy Clin Immunol; 1990 Feb; 85(2):530-1. PubMed ID: 2303654
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacokinetics of theophylline. Repeated single evening administration of Pulmo-Timelets slow-release capsules in comparison with theophylline slow-release tablets].
    Heusinger JH; Breuel HP; Behrendt WA; Wolfstädter HD
    Fortschr Med; 1989 Nov; 107(32):692-6. PubMed ID: 2689314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.